logo

TODAY'S TOP STORIES

Share

joebidenkamalaharris jan20 Stage is set outside the Capitol for Joseph R. Biden, Jr. to be sworn in as the 46th President of the United States at noon Wednesday. Biden, 78, and Vice President-elect Kamala Harris, 56, will be sworn in by Supreme Court Chief Justice John Roberts. Born to parents of Indian and Jamaican origins, Harris will become the first colored Asian-American to be elevated to the post. She will also becom

stockmarkets dec21 20jan21 What's moving these stocks in pre-market hours today?

asian up 20jan21 European stocks rose Wednesday on the back of a slew of positive earnings releases and new U.S. Treasury Secretary Janet Yellen's pledge to "act big" on stimulus to reinvigorate the world's largest economy hit by the coronavirus pandemic. Joe Biden will be sworn-in as the 46th President of the U.S...

uk flag 032917 20jan21 UK consumer price inflation doubled in December on higher transport and recreation costs, data released by the Office for National Statistics showed on Wednesday. Inflation accelerated to 0.6 percent from 0.3 percent in November. The rate was above economists' forecast of 0.5 percent. Month-on-month, consumer prices advanced 0.3 percent, reversing a 0.1 percent drop in November.

inozymepharma jan18 The lockup period of Boston, Massachusetts-based Inozyme Pharma (INZY) ends today, i.e., January 20, 2021. Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of calcification disorders of the circulatory system, bones, and kidneys.

iteostherapeutics jan18 The lockup period of Cambridge, Massachusetts-based iTeos Therapeutics (ITOS) expires on January 20, 2021. iTeos Therapeutics is a clinical-stage biopharmaceutical company developing immuno-oncology therapeutics.

biotech jan20 Today's Daily Dose brings you news about another Alzheimer's disease drug failure, encouraging data of Aclaris' rheumatoid arthritis trial; Royalty Pharma/Minerva deal; Gritstone joining the COVID-19 vaccine race; and FDA imposing a clinical hold on Histogen's planned trial of HST-003 for knee cartilage regeneration.

previewimage aug03 20jan21 Consumer and producer prices from the UK are due on Wednesday, headlining a light day for the European economic news. At 2.00 am ET, the Office for National Statistics is set to publish UK consumer and producer prices for December. Inflation is seen rising to 0.5 percent from 0.3 percent in November.

stockmarkets dec24 20jan21 European stocks are seen opening on a flat note Wednesday as investors weigh coronavirus worries against hopes of fresh U.S. stimulus. Covid infection rates are on the rise again in parts of Asia, with Tokyo and other parts of Japan currently under a state of emergency to quash a surge in infections. China's...

nurix jan18 The lockup period of San Francisco, California-based Nurix Therapeutics (NRIX) expires tomorrow , i.e., January 20, 2021. Nurix Therapeutics is a biopharmaceutical company developing oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders.

annexon jan18 The lockup period of South San Francisco, California-based Annexon (ANNX) expires tomorrow, i.e., on January 20. Founded in 2011, Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for autoimmune and neurodegenerative diseases.

netflix july30 19jan21 Netflix Inc. (NFLX) Tuesday reported a fourth-quarter profit that fell short of Wall Street estimates, despite revenues increasing 22% and beating expectations. The online-video streaming giant's subscriber additions trumped Wall Street's outlook, sending its shares up over 12% in the extended trading...

wallstreet aug28 19jan21 Stocks moved mostly higher during trading on Tuesday as traders returned to their desks following the long holiday weekend. The tech-heavy Nasdaq ended the session just shy of the record closing high set earlier this month.

wallstreet sep4 19jan21 Stocks have pulled back off their best levels of the day but remain mostly positive in mid-day trading on Tuesday. The major averages are holding on to gains after showing a strong move to the upside at the start of trading.

wallstreet oct16 19jan21 After showing a strong move to the upside at the start of trading on Tuesday, stocks have given back some ground over the course of the morning. The major averages have pulled back off their highs of the session but remain in positive territory.

Follow RTT